Annals of Internal Medicine | 2021
In postmenopausal women, multimodal or US screening for ovarian cancer did not reduce ovarian cancer mortality
Abstract
SOURCE CITATION\nMenon U, Gentry-Maharaj A, Burnell M, et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2021;397:2182-93. 33991479.